Status:
COMPLETED
Atlantis Symbicort
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether Symbicort compared with Advair, will be more effective in controlling asthma in adults and adolescents.
Eligibility Criteria
Inclusion
- Diagnosis of asthma
- Baseline lung function tests as determined by protocol
- Required and received treatment with inhaled corticosteroids within timeframe and doses specified in protocol
Exclusion
- Has required treatment with any non-inhaled corticosteroid within previous 30 days, sensitivity to drugs specified in the protocol, or requires treatment with a beta-blockers
- Had cancer within previous 5 years or currently has any other significant disease or disorder as judged by the investigator
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2005
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00646594
Start Date
November 1 2003
End Date
January 1 2005
Last Update
March 27 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.